What is IgA nephropathy?IgA nephropathy (also known as Berger’s disease) is a kidney disorder caused by the buildup of ...

"IgA Nephropathy Market Insight, Epidemiology And Market Forecast - 2034"The IgA Nephropathy (IgAN) treatment market is poised for substantial growth, driven by the introduction of innovative ...

Everest Medicines (HKEX 1952.HK, 'Everest' or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

The Company currently has a pipeline of programmes in development including the lead asset for treatment of IgA Nephropathy (IgAN) and other complement mediated kidney disease. The Company also has ...

ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

PS-002, Purespring’s lead precision nephrology programme, targets the complement pathway known to be a driver of IgA nephropathy IND clearance follows the granting of European Medicine Agency ...

Witnessing her son's ongoing pain and deteriorating health, his mother took the brave decision to donate one of her kidneys. On July 1, a team of specialists at the hospital performed the transplant.

A dual algorithm claims analysis revealed the rare burden of primary IgA nephropathy in Germany and underscored the need for precise diagnostic coding.

We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Novartis AG stands third among the most undervalued ...

Vera Therapeutics Inc. (NASDAQ:VERA) is one of the best high short interest stocks with huge upside potential. Earlier in June, Vera Therapeutics announced positive topline results from its ongoing ...

Game Changers in Nephrology' was the theme of the 62nd European Renal Association (ERA) Congress, held in Vienna, ...